Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,619 across all filing types
Latest filing 2019-04-26 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
2018年度独立董事述职报告（谷杨）
Board/Management Information Classification · 95% confidence The document is titled '2018年度独立董事述职报告（谷杨）' which translates to '2018 Annual Independent Director's Work Report (Gu Yang)'. It is a detailed report by an independent director on their duties and opinions regarding various company matters during the 2018 fiscal year. The content includes independent opinions on board meeting resolutions, compliance with laws and regulations, corporate governance, financial and operational matters, and shareholder interests. It is not a financial statement or audit report but a management-related report focusing on the independent director's role and activities. This fits the category of Board/Management Information (MANG), which covers announcements or reports related to changes or activities of the board or senior management. The document is lengthy (7,984 characters) and contains substantive content rather than a brief announcement or certification. Therefore, the best classification is MANG with high confidence.
2019-04-26 Chinese
2018年年度报告
Annual Report Classification · 100% confidence The document is titled "深圳市海王生物工程股份有限公司 2018 年年度报告全文" which translates to "Shenzhen Neptunus Bioengineering Co., Ltd. 2018 Annual Report Full Text." It contains detailed sections typical of an annual report, including company overview, financial data for the year 2018, management discussion and analysis, business overview, financial statements, and governance information. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. It includes audited financial data, management statements, and comprehensive business and financial analysis for the full fiscal year 2018. There is no indication that this is merely an announcement or a summary; it is the full annual report itself. Therefore, the correct classification is Annual Report (10-K). FY 2018
2019-04-26 Chinese
2018年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2018 Annual Report Summary" of Shenzhen Haier Bioengineering Co., Ltd. It contains detailed financial data for the year 2018, including revenue, net profit, segment business descriptions, accounting policy changes, bond information, shareholder information, and management discussion and analysis. The document is comprehensive and covers the full fiscal year 2018, consistent with an annual report. It is not a brief announcement or a presentation, nor is it a transcript or a proxy statement. The length (15,000 characters) and detailed financial and operational data confirm it is the actual annual report document, not just an announcement or summary. Therefore, the correct classification is Annual Report (10-K). FY 2018
2019-04-26 Chinese
2019年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "深圳市海王生物工程股份有限公司 2019 年第一季度报告全文" which translates to "Shenzhen Haiwang Bioengineering Co., Ltd. 2019 First Quarter Report Full Text." It contains detailed financial data including consolidated balance sheets, profit and loss statements, and notes on financial performance for the first quarter of 2019. The presence of quarterly financial statements and comprehensive financial metrics indicates this is a quarterly financial report. The document length is about 15,000 characters, which is consistent with a full interim report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-26 Chinese
2019年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 年第一季度报告正文" which translates to "2019 First Quarter Report". It contains detailed financial data such as revenue, net profit, cash flow, and other financial indicators for the first quarter of 2019. It also includes sections on shareholder information, important matters during the reporting period, and management commentary on financial changes and company activities. The length of the document (7295 characters) and the presence of substantive financial data and analysis confirm it is a comprehensive quarterly report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-26 Chinese
2018年度监事会工作报告
Board/Management Information Classification · 95% confidence The document is titled as the "2018年度监事会工作报告" which translates to "2018 Supervisory Board Work Report". It details the supervisory board's activities, oversight of financial reports, compliance with laws and regulations, and plans for 2019. It includes references to monitoring the company's financial reports and internal controls but does not itself contain full financial statements or detailed financial data. The document is a report on the supervisory board's work and oversight rather than a full annual report or audit report. Given the nature of the content focusing on supervisory board activities and oversight, this fits best under the category of Board/Management Information (MANG). The document length is 2774 characters, which is relatively short and consistent with a report rather than a full financial statement. Therefore, the classification is MANG with high confidence.
2019-04-26 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.